Raptor Pharmaceutical Corp. (NASDAQ:RPTP) closed its last session at $8.96 The market capitalization of the company is $764.34M with an average Volume of 1.75 million shares. The stock currently has its 52-Week High range of $8.97 and 52-week low range of $2.94. The Price to Book (P/B) ratio stands at 11.33. The stock traded total quantity of 5.28 million shares.
Currently Raptor Pharmaceutical Corp. (RPTP) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “2″ Analysts”. “0” rated “Sell” for the company. “2” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $9.00 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $10.00 however minimum price target advised by analysts is $8.00. The Median price target for the stock is measured at $9.00.
Presently, Analysts decided consensus EPS estimate of $-0.15 for present quarter and one month ago projected EPS estimate was at $-0.14. If we take a look at back 3 month ago, consensus EPS estimate was $-0.16.
A current consensus EPS estimate for next quarter is at $-0.12 and 3 month ago EPS forecast was $-0.15. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.11.
For current fiscal year, most recent EPS estimate is set at $-0.91 based on Analyst consensus and three month ago consensus EPS opinions was at $-0.97. During period one month ago, consensus EPS forecast was decided at $-0.90.
A current consensus EPS projection for next fiscal year is observed at $-0.33 and one month ago consensus EPS forecast was at $-0.37. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-0.40 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 3 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 3 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 4 said a “Buy Rating” and 0 announced “Overweight Rating”. 3 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.